查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198344

竇擴張器市場-增長、趨勢、COVID-19 影響和預測 (2023-2028)

Sinus Dilation Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在本研究的預測期內，鼻竇擴張器市場預計將以 8.8% 的複合年增長率增長。

COVID-19 大流行擾亂了常規患者護理。 許多醫療機構取消了例行就診和擇期手術，並重組了醫護人員，以增加和維持重症監護病房和住院床位。 這妨礙了患者的護理，尤其是慢性鼻炎患者。 患者選擇了遠程醫療和鼻竇相關問題的臨時選擇。 例如，根據 2020 年 10 月發表的題為“COVID-19 大流行對美國門診和手術室鼻科實踐的影響”的研究，在辦公室環境和鼻竇手術中進行面對面的諮詢和手術顱底疾病 在日本，只有 1.1% 的門診手術室和醫院手術室允許選擇性病例，這對鼻科實踐產生了重大影響。 因此，雖然該數據顯示了 COVID-19 對市場的負面影響，但病例數下降、SARS-CoV-2 病毒對人類的長期影響以及全球大規模疫苗計劃已經推動研究市場有望在研究預測期內完全恢復其增長潛力。

由於微創手術具有切口更小、疤痕更少、精度更高、並發症風險更低以及住院時間更短等優點，因此越來越受歡迎，需求也越來越大，這導致全世界的鼻竇炎負擔沉重。加上預計成為推動鼻竇擴張器市場增長的關鍵增長因素。 例如，2021 年 12 月發表的一項題為“基於鼻竇放射學和基於症狀的流行率的慢性鼻鼻竇炎在普通人群中的流行率”的研究發現，基於證據的慢性鼻鼻竇炎 (CRS) 的流行率為 3% 至 6.4% .

此外，越來越多的手術和對微創手術的需求增加預計會增加對鼻竇擴張產品的需求，這有望在研究的預測期內推動監測市場的增長。 例如，根據一項於 2021 年 7 月發表的題為“過去十年英國鼻竇手術的演變——一項觀察性研究”的研究報告，在 2010 年至 2019 年期間，英國約有 89,495 人進行了內窺鏡手術，並增加了 21.1%。上頜骨、額葉和蝶骨手術的整體增長。 因此，隨著鼻竇相關手術數量的增加，對鼻竇擴張產品的需求有望增加，從而推動所研究市場的增長。

此外，該領域主要市場參與者在鼻竇擴張器方面的技術進步數量正在增加，這將對研究預測期內鼻竇擴張器市場的增長產生積極影響。更值得期待。 例如，在 2021 年，Intersect ENT（美國）宣布推出與 PROPEL Mini Sinus Implant 配套的新型直接輸送系統。 因此，隨著諸如此類的發展和創新，竇擴張器的使用預計會在未來幾年增加，預計會對研究市場產生積極影響。

然而，在預測期內，鼻竇手術相關的風險、並發症以及熟練醫務人員短缺等因素預計將抑制鼻竇擴張器市場的增長。

鼻竇擴張器的市場趨勢

在預測期內，球囊竇擴張器預計將在產品領域佔據較大的市場份額

由於慢性鼻竇炎患者對藥物反應不佳，需要緩解鼻竇炎的不適和疼痛症狀，因此需要一種安全有效的慢性鼻竇炎治療方法。球囊鼻竇擴張裝置的需求預計將超過預測在此期間，隨著球囊擴張鼻竇手術的數量在全球範圍內不斷增加，調查市場也在推動增長。 這是因為球囊擴張鼻竇對鼻竇的創傷小，能有效緩解慢性鼻竇炎的症狀，術後恢復快。 市場上有多種氣囊鼻竇擴張器設備，包括美敦力的 NuVent 氣囊鼻竇擴張系統、史賽克公司的 Audion ET 擴張系統和 Meril Life Sciences 的 Mesire 鼻竇氣囊導管。

Daniel H. Lofgren 和 Carl Schermetallo 於 2021 年 12 月對球囊鼻竇整形術進行的回顧性研究發現，在過去十年中，慢性鼻竇炎 ( 使用球囊鼻竇整形術治療 CRS 的人數顯著增加。 越來越多的患者選擇這種治療方法，因為它並發症風險低、恢復快、創傷小。 因此，預計該行業在本研究的預測期內將佔據很大的市場份額。

此外，在研究預測期內，進一步改進球囊竇擴張器的持續研發活動，加上技術創新和新設備的推出，預計將進一步增加對球囊竇擴張器的需求。 例如，2021 年 6 月，Intersect ENT 在美國推出了先進的 VenSure 球囊竇擴張系統以及 Cube 4D 導航系統。 VenSure 球囊和 Cube 4D 導航系統用於改善衰弱性慢性鼻竇炎 (CRS) 症狀的手術中。 因此，由於上述因素，球囊竇擴張器部分預計在預測期內將佔據產品部分的很大份額。

預計在預測期內北美將佔很大份額

按地區劃分，北美地區預計將佔據鼻竇擴張器市場的很大份額。 這是由於存在強大的醫療保健基礎設施、鼻竇炎和相關疾病的高負擔、新產品的推出、導致鼻竇炎的風險因素負擔增加，例如吸煙、慢性感冒、過敏、哮喘和頭部受傷。這是由於以下因素例如 例如，根據加拿大煙草和尼古丁調查 (CTNS)。 根據 2021 年的總結結果，大約 13.3%（330 萬）的 25 歲以上的加拿大人說他們吸煙，而男性（13%，170 萬）和女性（12%，160 萬）報告了類似的當前情況吸煙率。 因此，預計該地區的鼻竇炎負擔將增加，在預測期內推動對鼻竇擴張器的需求，從而促進研究市場的增長。

在北美地區，由於鼻竇炎負擔高，主要市場參與者在該國的存在，以及鼻竇炎危險因素的高負擔和患病率，美國是一個巨大的研究市場。預計將採取分享。 例如，根據美國疾病控制與預防中心 (CDC) 2022 年 1 月更新，美國約有 2890 萬成年人被診斷出患有鼻竇炎，約佔全國成年人口總數的 11.6%。 此外，約有 270 萬人前往主要疾病為鼻竇炎的診所就診。 因此，鼻竇炎的高負擔有望成為美國鼻竇擴張器市場增長的主要驅動力。

此外，與鼻竇炎相關的吸煙和哮喘等危險因素在該國頻繁發生。 此外，還有許多與鼻竇炎相關的風險因素，例如吸煙和哮喘，這些因素預計會增加鼻竇炎的負擔，並推動對鼻竇擴張器的治療需求增加。 例如，根據 2022 年 5 月在 CDC 網站上發布的國家環境衛生中心關於哮喘的報告，2020 年將有大約 2530 萬人（包括兒童和成人）患有哮喘，其中 35 歲最常見於 64 歲至歲年齡組。 因此，由於上述因素，預計在預測期內美國將佔據北美地區研究市場的很大份額。

鼻竇擴張器市場競爭對手分析

全球鼻竇擴張器市場競爭適中。 它由 Smith and Nephew、Johnson & Johnson Inc.、Medtronic、Meril Life Sciences Private Limited 和 Olympus Corporation 等幾家主要參與者組成。 隨著主要市場參與者的新設備發布、併購、合作夥伴關係和其他業務擴展活動，預計市場競爭將變得更加激烈。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 對微創手術的需求不斷增長，鼻竇炎患病率不斷上升
    • 鼻竇擴張裝置的技術進步
  • 市場製約因素
    • 與鼻竇手術相關的風險
    • 缺乏熟練的專業人員
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（金額基礎：百萬美元）

  • 按產品分類
    • 球囊竇擴張器
    • 鼻竇植入物
    • 手持設備
    • 內窺鏡
    • 其他產品
  • 通過方法
    • 獨立的竇擴張術
    • 混合竇擴張術
  • 最終用戶
    • 醫院
    • 專科診所
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • Intersect ENT, Inc.
    • Johnson & Johnson
    • Medtronic Plc
    • Meril Life Sciences Private Limited
    • Olympus Corporation
    • SinuSys Corporation
    • Smith & Nephew
    • Stryker Corporation
    • Creganna
    • Dalent Medical
    • InnAccel
    • Accurate Surgical & Scientific Instruments

第7章 市場機會與今後動向

簡介目錄
Product Code: 67153

The sinus dilation market is expected to register a CAGR of 8.8% during the forecast period of the study.

The COVID-19 pandemic led to interruptions in routine patient care. Many healthcare organizations have canceled routine clinic visits and elective surgeries to increase and maintain the availability of intensive care and inpatient care beds and have reorganized medical and nursing staff. This has particularly interrupted care for patients with chronic rhinitis. The patients opted for teleconsultations and temporary options for sinus-related problems. For instance, according to a research study published in October 2020, titled "Impact of COVID-19 Pandemic on Ambulatory and Operating Room Rhinology Practice in the US", there was a significant impact of COVID-19 on rhinology practice as the number of in-person care in the office environment and surgical management of sino-nasal and skull base illness has dramatically decreased, with only 1.1% of ambulatory surgery center/hospital operating rooms were allowing elective cases in the country. Hence, this data shows a negative impact of COVID-19 on the market, however, with the decreasing number of cases, long-term impact of SARS-CoV-2 virus on humans, and large-scale vaccination programs around the world, the studied market is expected to regain its full growth potential over the forecast period of the study.

The increasing popularity and demand for minimally invasive surgeries owing to its benefits such as smaller incisions, less scarring, high accuracy and decreased risk of complications, shorter hospital stays, and others, coupled with the high burden of sinusitis around the world are expected to be significant growth factors that are fueling growth in the sinus dilation devices market. For instance, according to the research study published in December 2021, titled "Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology", the prevalence of clinically based chronic rhinosinusitis (CRS) was 3% to 6.4%.

Further, with the growing number of surgeries and increasing demand for minimally invasive surgical procedures, the demand for sinus dilation products is expected to increase which will boost growth in the studied market over the forecast period of the study. For instance, according to a research study published in July 2021, titled "The evolution of sinus surgery in England in the last decade - An observational study", in England, between 2010 and 2019, about 89,495 sinus procedures were performed, with 21.1% increase in the endoscopic surgeries and overall increase in the maxillary, frontal and sphenoid sinus procedures. Hence, with the rising number of sinus-related surgeries, the demand for sinus dilation products is expected to increase which is expected to fuel growth in the studied market.

Additionally, a growing number of technological advancements in sinus dilation devices by the key market players in the area are further expected to have a positive impact on the growth of the sinus dilation devices market during the forecast period of the study. For example, in 2021, Intersect ENT (US) announced the launch of the new Straight Delivery System packaged with the PROPEL Mini Sinus Implant. Therefore, with developments and innovations like these, the use of sinus dilation devices is expected to increase over the years which is anticipated to have a positive impact on the studied market.

However, factors such as risks, complications associated with sinus surgeries, and lack of skilled healthcare professionals are expected to restrain the growth of the sinus dilation devices market during the forecast period.

Sinus Dilation Devices Market Trends

Balloon Sinus Dilation Device is Expected to Hold Significant Market Share in the Product Segment During Forecast Period

Patients with chronic sinusitis who are not responding well to medication and need relief from uncomfortable and painful sinusitis symptoms can benefit from the balloon sinus dilation procedure which is a safe and effective procedure for chronic sinusitis and there are several other advantages of balloon sinus dilation due to which the number of balloon sinus dilation procedures is increasing around the world and thus, the demand for balloon sinus dilation devices is expected to increase over the forecast period and driving growth in the studied market. For example, it is a less invasive procedure, effective at relieving symptoms of chronic sinusitis, faster post-operative recovery time, and others. There are several balloon sinus dilation devices available in the market such as the NuVent balloon sinus dilation system from Medtronic, Audion ET dilation system from Stryker Corporation, Mesire Sinus Balloon Catheter from Meril Life Sciences, among many others.

According to a review study published by Daniel H. Lofgren and Carl Shermetaro in December 2021 on balloon sinuplasty, over the past ten years, the use of balloon sinuplasty for the treatment of chronic rhinosinusitis (CRS) that is resistant to conventional medical therapy has significantly increased. The number of patients choosing to undergo this procedure is increasing because of its decreased risk of complications, quicker recovery time, and minimally invasive nature. Hence, this segment is expected to have a significant market share during the forecast period of the study.

Moreover, the ongoing research and development activities on further improving the balloon sinus dilation devices coupled with the technological innovations and launch of new devices are further expected to boost the demand for balloon sinus dilation devices during the forecast period of the study. For instance, in June 2021, Intersect ENT launched an advanced VenSure balloon sinus dilation system along with Cube 4D navigation system in the United States. The VenSure Balloon and Cube 4D Navigation Systems are used in procedures that are designed to improve debilitating chronic rhinosinusitis (CRS) symptoms. Therefore, due to the above-mentioned factors, the balloon sinus dilation devices segment is expected to hold a significant share in the product segment over the forecast period.

North America is Expected to Hold a Significant Share in the Market Over the Forecast Period

By geography, the North American region is expected to occupy a significant share in the sinus dilation devices market due to the factors such as the presence of robust healthcare infrastructure, high burden of sinusitis and related diseases, the launch of new products, and increased burden of risks factors causing sinusitis in the region such as smoking, chronic cold, allergies, asthma, head injury, and other factors. For instance, according to the Canadian Tobacco and Nicotine Survey (CTNS): Summary of Results for 2021, approximately 13.3% (3.3 million) of Canadian people aged 25 and over reported smoking cigarettes, and men (13% or 1.7 million) and women (12% or 1.6 million) both reported a similar level of current smoking prevalence. Hence, the burden of sinusitis is expected to increase in the region, driving demand for sinus dilation devices over the forecast period and boosting growth in the studied market.

In the North American region, the United States is expected to hold a significant market share in the studied market owing to the high burden of sinusitis, the presence of some of the key market players in the country, and the high burden and prevalence of risk factors for sinusitis. For instance, according to the January 2022 update of the Centers for Disease Control and Prevention (CDC), about 28.9 million adults in the United States are diagnosed with sinusitis which is about 11.6% of the total adult population of the country. Further, as per the same source, about 2.7 million visits are made to physician offices with chronic sinusitis as the primary diagnosis in the country. Thus, the high burden of sinusitis is expected to be the major driving factor for the growth of the sinus dilation devices market in the United States.

Further, the risk factors associated with sinusitis such as smoking and asthma, are highly prevalent in the country. They are further expected to increase the burden of sinusitis in the country and thus, fuel growth in the demand for sinus dilation devices for their treatment. For instance, according to the National Center for Environmental Health's report on asthma published in May 2022 on CDC's website, about 25.3 million people (children and adults both) had asthma in 2020 and it was most prevalent among the age group of 35-64 years. Therefore, owing to the factors mentioned above, the United States is expected to hold a significant share in the studied market in the North American region over the forecast period.

Sinus Dilation Devices Market Competitor Analysis

The global sinus dilation devices market is moderately competitive. It comprises several significant players such as Smith and Nephew, Johnson & Johnson Inc., Medtronic, Meril Life Sciences Private Limited, and Olympus Corporation, among many others. The market is expected to grow more competitive with the launch of new devices, mergers and acquisitions, partnerships and other business expansion activities by the key market players.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Minimally Invasive Procedures and Increasing Prevalnce of Sinusitis
    • 4.2.2 Technological Advancements in Sinus Dilation Devices
  • 4.3 Market Restraints
    • 4.3.1 Risks Associated with Sinus Surgeries
    • 4.3.2 Lack of Skilled Specialists
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value in USD Million)

  • 5.1 By Product
    • 5.1.1 Balloon Sinus Dilation Devices
    • 5.1.2 Sinus Implants
    • 5.1.3 Handheld Instruments
    • 5.1.4 Endoscopes
    • 5.1.5 Other Products
  • 5.2 By Procedure
    • 5.2.1 Standalone Sinus Dilation Procedures
    • 5.2.2 Hybrid Sinus Dilation Procedures
  • 5.3 By End-User
    • 5.3.1 Hospital
    • 5.3.2 Specialty Clinic
    • 5.3.3 Other End-Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Intersect ENT, Inc.
    • 6.1.2 Johnson & Johnson
    • 6.1.3 Medtronic Plc
    • 6.1.4 Meril Life Sciences Private Limited
    • 6.1.5 Olympus Corporation
    • 6.1.6 SinuSys Corporation
    • 6.1.7 Smith & Nephew
    • 6.1.8 Stryker Corporation
    • 6.1.9 Creganna
    • 6.1.10 Dalent Medical
    • 6.1.11 InnAccel
    • 6.1.12 Accurate Surgical & Scientific Instruments

7 MARKET OPPORTUNITIES AND FUTURE TRENDS